Prior to administering oral doses of calcitriol and calcium carbonate to a client with hypoparathyroidism, the nurse notes that the client's total calcium level is 14 mg/dl (3.5 mmol/l) Which action should the nurse implement? Reference Range: Calcium 8.5 to 10.5 mg/dL (2.25 to 2.75 mmol/L)

A. Administer both prescribed medications as scheduled: Given that the client's total calcium level is already elevated (14 mg/dL), administering additional calcium carbonate could exacerbate hypercalcemia. Calcitriol, a form of vitamin D, can also increase calcium levels, so administering it without addressing the high calcium level could worsen the condition. B. Hold the calcium carbonate, but administer the calcitriol as scheduled: This option is not appropriate because calcitriol can further increase calcium levels, potentially worsening hypercalcemia. Both medications should be reviewed, and their administration should be adjusted according to the client's current calcium status. C. Hold the calcitriol, but administer the calcium carbonate as scheduled: Holding calcitriol alone would not address the potential for further increasing calcium levels. Calcium carbonate should also be withheld since the client is already hypercalcemic. D. Hold both medications until contacting the healthcare provider: This is the most appropriate action. The client's elevated calcium level indicates hypercalcemia, which requires careful management. The healthcare provider should be contacted to assess the situation and determine the appropriate course of action to avoid worsening hypercalcemia.